2581 - 2590 of 6433 Results
Title
Year
-
OPENTitle: Novel method to ascertain chromatin accessibility at specific genomic loci from frozen brain homogenates and laser capture microdissected defined cellsJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.03.001Best OA location URL: https://doi.org/10.1016/j.nepig.2016.03.001Citation Count: 0
-
OPENTitle: Differential involvement of Ras‐GRF1 and Ras‐GRF2 in L‐DOPA‐induced dyskinesiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 6Start Page: 662End Page: 678Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.202Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.202Citation Count: 20
-
OPENTitle: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 42Issue #: 3Start Page: 327End Page: 340Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024Best OA location URL: https://lup.lub.lu.se/record/1831976Citation Count: 169
-
OPENTitle: Investigating the ageing-Parkinson’s disease nexus: standardisation of in vitro models and techniques by the PD-AGE networkJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01137-2Best OA location URL: https://doi.org/10.1038/s41531-025-01137-2Citation Count: 0
- TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite Effects2018OPENTitle: TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite EffectsJournal Name: Journal of Molecular NeurosciencePublisher: Springer Science and Business Media LLCVol: 64Issue #: 3Start Page: 341End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12031-018-1031-4Best OA location URL: https://zenodo.org/record/3911331Citation Count: 12
-
OPENTitle: Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 288End Page: 297Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.09.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6386531Citation Count: 82
-
OPENTitle: Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 10Start Page: 949End Page: 959Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.246Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.246Citation Count: 172
- Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia2016OPENTitle: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasiaJournal Name: CortexPublisher: Elsevier BVVol: 83Issue #:Start Page: 124End Page: 135Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cortex.2016.07.004Best OA location URL: https://doi.org/10.1016/j.cortex.2016.07.004Citation Count: 20
-
OPENTitle: GBA mutations in Parkinson disease: earlier death but similar neuropathological featuresJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 11Start Page: 1363End Page: 1368Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13395Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5657539Citation Count: 29
-
OPENTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8369681Citation Count: 24